SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-023684
Filing Date
2024-02-14
Accepted
2024-02-14 16:17:24
Documents
1
Group Members
5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS VI, LLCANDREW J. SCHWABDR. KUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm245508d1_sc13da.htm SC 13D/A 103198
  Complete submission text file 0001104659-24-023684.txt   104988
Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Subject) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92269 | Film No.: 24638549
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)